Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Kim A. Papp
Based on 50 articles published since 2009
(Why 50 articles?)
||||
Expertise Level
The expertise of Kim A. Papp ranks in the
  • Top 0.092%
  • ... of 37,126 published authors worldwide on Psoriasis
  • ... from 2009 through 2019
  • ... based on contributions to 50 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Waterloo      
2019
  • Keck School of Medicine of USC, University of Southern California, 1975 Zonal Avenue, Keith Administration Building, Room 510, Los Angeles, CA, 90089, USA. · Dermatologikum Berlin, Berlin, Germany. · SCIderm Research Institute, Hamburg, Germany. · The University of Melbourne, St. Vincent's Hospital Melbourne, Fitzroy and Probity Medical Research Inc., and Skin & Cancer Foundation Inc., Carlton, VIC, Australia. · Janssen Research & Development, LLC, Spring House, PA, USA. · K Papp Clinical Research and Probity Medical Research Inc., Waterloo, ON, Canada. · Pubmed 30417277
2018
  • Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · The McGovern School of Medicine of the University of Texas, Houston, Texas; Brain Health Consultants, Houston, Texas. · University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, California. · Oregon Medical Research Center, Portland, Oregon. · Skin Centre for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Valeant Pharmaceuticals North America LLC, Bridgewater, New Jersey. · Dow Pharmaceutical (a division of Valeant Pharmaceuticals North America LLC), Petaluma, California. · Pubmed 28985956
  • Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: · University of Connecticut Health Center and Probity Medical Research, Farmington, CT, USA. · Icahn School of Medicine at Mount Sinai, New York, NY, USA. · University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Oregon Medical Research Center, Portland, OR, USA. · Centre Dermatologique du Québec Métropolitain, Québec, QC, Canada. · K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · University of California, Los Angeles, CA, USA; School of Medicine, Los Angeles, CA, USA. · Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Melbourne, Parkville, Skin & Cancer Foundation Inc, Carlton, Probity Medical Research, Carlton, and St Vincent's Hospital Melbourne, Fitzroy VIC, Australia. · Jichi Medical University, Shimotsuke, Japan. · Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA. · AbbVie, North Chicago, IL, USA. · AbbVie, Redwood City, CA, USA. · Saint-Louis Hospital, AP-HP, Sorbonne Paris Cité Université Paris Diderot, INSERUM UMR 1163, Institut Imagine, Paris, France. Electronic address: · Pubmed 30097359
  • 1 K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · 2 Faculty of Medicine, Sherbrooke University, Sherbrooke, QC, Canada. · 3 Centre de Recherche Dermatologique du Québec Métropolitain, Quebec, QC, Canada. · 4 Lynde Institute for Dermatology and Probity Medical Research, Markham, ON, Canada. · 5 CHU de Québec, Laval University, Quebec, QC, Canada. · 6 Amgen Canada, Mississauga, ON, Canada. · Pubmed 29466863
  • Department of Dermatology, New York Medical College, Metropolitan Hospital, New York, New York. Electronic address: · K Papp Clinical Research and Probity Medical Research, Waterloo, Ontario. · Department of Medicine, University of Massachusetts School of Medicine, Worcester, Massachusetts. · Eli Lilly and Company, Indianapolis, Indiana. · Department of Rheumatology Research, Swedish-Providence-St. Joseph Health Systems and University of Washington School of Medicine, Seattle, Washington. · Pubmed 29559395
  • Probity Medical Research, and K. Papp Clinical Research, Waterloo, Ontario, Canada. · Analysis Group Inc., Boston, MA, USA. Electronic address: · AbbVie Inc., North Chicago, IL, USA. · Analysis Group Inc., Boston, MA, USA. · Pubmed 29304933
  • 1 University of Ottawa, Ottawa, ON, Canada. · 2 University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 SkiN Centre for Dermatology, Peterborough, ON, Canada. · 5 Probity Medical Research Inc., Waterloo, ON, Canada. · 6 University of Waterloo, Waterloo, ON, Canada. · 7 K. Papp Clinical Research, Waterloo, ON, Canada. · Pubmed 29056080
2017
  • Sapporo Skin Clinic, Sapporo, Japan. · Division of Dermatology, Kobe University, Kobe, Japan. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Kumamoto University, Kumamoto, Japan. · JR Sapporo Hospital, Sapporo, Japan. · Pfizer Japan Inc, Tokyo, Japan. · Pfizer Inc, New York, USA. · Probity Medical Research and K. Papp Clinical Research Inc., Waterloo, Ontario, Canada. · Pubmed 28714180
  • SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany. Electronic address: · Probity Medical Research, Waterloo, ON, Canada. · Oregon Medical Research Center, Portland, OR, USA. · Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA. · Epworth Hospital Department of Dermatology, University of Melbourne, Melbourne, VIC, Australia. · Comprehensive Center for Inflammation Medicine, University Medical School Schleswig-Holstein, University of Lübeck, Lübeck, Germany. · Merck & Co, Kenilworth, NJ, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 28596043
  • Bakersfield Dermatology, Bakersfield, California. Electronic address: · Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Germany. · Department of Dermatology, Hôpital Charles Nicolle, Université de Rouen, Rouen, France; Institut National de la Santé et de la Recherche Médicale U519, Rouen, France. · Catholic University of Rome, Rome, Italy. · Probity Medical Research, Waterloo, Ontario, Canada. · Celgene Corporation, Summit, New Jersy. · Hospital Universitario Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain. · Modern Research Associates, Dallas, Texas. · Pubmed 28416342
  • Oregon Medical Research Center, Portland, Oregon. Electronic address: · K. Papp Clinical Research and Probity Research Inc, Waterloo, Ontario, Canada. · Dermatology Center, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Center, Manchester, United Kingdom. · Janssen Research & Development LLC, Spring House, Pennsylvania; Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. · Janssen Research & Development LLC, Spring House, Pennsylvania. · Department of Dermatology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Pubmed 28057360
  • Department of Dermatology, University of Connecticut Health Center and Probity Medical Research, Farmington, Connecticut. Electronic address: · Central Dermatology PC, St Louis, Missouri. · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Psoriasis-Center, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Jichi Medical University, Shimotsuke, Tochigi, Japan. · Innovaderm Research, Montreal, Canada. · Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Dermatology, Paul Sabatier University, Toulouse, France. · Icahn School of Medicine at Mount Sinai, New York, New York. · Eli Lilly and Company, Indianapolis, Indiana. · Dermatologikum Hamburg and SCIderm, Hamburg, Germany. · Pubmed 27889292
  • Oregon Medical Research Center, Portland, Oregon. Electronic address: · Probity Medical Research, Waterloo, Ontario, Canada. · Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Dermatology, Temple University School, Philadelphia, Pennsylvania. · Department of Dermatology, Baylor College of Medicine, Houston, Texas. · Dow Pharmaceutical Sciences (a division of Valeant Pharmaceuticals North America, LLC), Petaluma, California. · Valeant Pharmaceuticals North America LLC, Bridgewater, New Jersey. · Pubmed 28711089
2016
  • K Papp Clinical Research and Probity Medical Research Inc, Waterloo, ON, Canada. · Innovaderm Research, Montreal, QC, Canada. · SKiN Centre for Dermatology and Probity Medical Research Inc, Peterborough, and Queens University, Kingston, ON, Canada. · Wake Forest Baptist Health, Winston-Salem, NC, USA. · Aarhus University Hospital, Aarhus, Denmark. · Southern California Dermatology, Santa Ana, CA, USA. · Dermatology Consulting Services, High Point, NC, USA. · Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business, Groton, CT, USA. · Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business, Groton, CT, USA. · Pubmed 27716172
  • Probity Medical Research, 139 Union Street East, Waterloo, ON, N2J 1C4, Canada. · Department of Dermatology, University of Southern California, Los Angeles, CA, USA. · Dermatologikum Hamburg, Hamburg, Germany. · AbbVie Inc., North Chicago, IL, USA. · Pubmed 26547918
  • Skin Centre for Dermatology, Peterborough, Ontario, Canada · Amgen Canada Inc, Mississauga, Ontario, Canada. · K Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Pubmed 26330052
  • University of Connecticut School of Medicine, Farmington, Connecticut. Electronic address: · Probity Medical Research, Waterloo, Ontario, Canada; K. Papp Medical Research, Waterloo, Ontario, Canada. · Icahn School of Medicine at Mount Sinai, New York, New York. · Dermatologikum Hamburg, Hamburg, Germany. · Paul Sabatier University, Toulouse, France. · Oregon Medical Research Center, Portland, Oregon. · Northwestern University, Feinberg School of Medicine, Chicago, Illinois. · Amgen Inc, Thousand Oaks, California. · Pubmed 27206759
  • Probity Medical Research and K. Papp Clinical Research Inc, Waterloo, Ontario, Canada. · Rockefeller University, New York, New York. · Wake Forest Baptist Health, Winston-Salem, North Carolina. · Dalhousie University, Halifax, Nova Scotia, Canada. · Comprehensive Center for Inflammation Research, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Department of Dermatology, University of Texas Medical School, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Cambridge, Massachusetts. · Dermatology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 26899199
  • Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: · Probity Medical Research, Waterloo, ON, Canada. · Eli Lilly & Co, Indianapolis, IN, USA. · Pubmed 26842297
2015
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA. · Department of Dermatology, University of Texas Medical School, Houston, TX, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Quintiles, Cambridge, MA, USA. · Present address: Statistical Consulting & Solutions, LLC, Brookline, MA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Specialty Care Medicines Development Group, Pfizer Inc, 219 E 42nd Street, 7th Floor Room 50, NYO 219/07/01, New York, NY, 10017, USA. · Pubmed 25951857
  • Baylor University Medical Center, Dallas, Texas. Electronic address: · Comprehensive Center for Inflammation Medicine, University Medical School Schleswig Holstein, Campus Lübeck, Lübeck, Germany. · Probity Medical Research, Waterloo, Ontario, Canada. · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · AbbVie Deutschland GmbH and Co KG, Ludwigshafen, Germany. · AbbVie Inc, North Chicago, Illinois. · Pubmed 26190240
  • Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · Probity Medical Research Inc, Waterloo, ON, Canada. · Oregon Medical Research Center PC, Portland, OR, USA. · Skin Search of Rochester, Rochester, NY, USA. · Innovaderm Research Inc, Montreal, QC, Canada. · Dermatology Clinic, Moncton, NB, Canada. · International Dermatology Research, Montreal, QC, Canada. · Ultranova Skincare, Barrie, ON, Canada. · Centre de Recherche Dermatologique du Québec Métropolitain, Quebec City, QC, Canada. · North Bay Dermatology Centre, North Bay, ON, Canada. · Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Novartis Institutes for BioMedical Research, Basel, Switzerland. · Pubmed 25828362
2013
  • Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington. Electronic address: · University of Toronto, Toronto, Ontario, Canada. · Probity Medical Research, Waterloo, Ontario, Canada. · Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada. · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Specialty Care, Pfizer Inc, Collegeville, Pennsylvania. · Pubmed 23981683
2012
  • Probity Medical Research, Waterloo, ON. · Pubmed 22713438
  • Probity Medical Research, Waterloo, Ontario, Canada. · Dermatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia. · Department of Medicine (Dermatology) and Department of Dermatology, The University of Melbourne, St Vincent's Hospital Melbourne, Melbourne, Victoria and Skin and Cancer Foundation, Carlton, Victoria, Australia. · Pharmacokinetics and Drug Metabolism, Amgen, Seattle, Washington, USA. · Early Development, Amgen, Thousand Oaks, California, USA. · Biostatistics, Amgen, South San Francisco, California, USA. · Rockefeller University, New York, New York, USA. · Medical Sciences, Amgen, Seattle, Washington, USA. · Medical Sciences, Amgen, Seattle, Washington, USA. Electronic address: · Pubmed 22622425
  • Probity Medical Research, Waterloo, ON, Canada. · Pubmed 22455412
  • Probity Medical Research, Waterloo, Ontario, Canada. · Pubmed 20850895
  • Probity Medical Research, Waterloo, Ontario, Canada. · Pubmed 23134986
2011
2010
Probable:    Miscellaneous cities in Canada      
2018
  • Probity Medical Research and K Papp Clinical Research, Waterloo, Canada. Electronic address: · Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts. · New York Medical College, Metropolitan Hospital, New York, New York. · Dermatology Centre, Salford Royal Hospital, University of Manchester, National Institute for Health Research Biomedical Research Centre, Manchester, United Kingdom. · UCB Biosciences Inc, Raleigh, North Carolina. · UCB Pharma, Brussels, Belgium. · Oregon Medical Research Center, Portland, Oregon. · Pubmed 29609013
2017
  • Oregon Medical Research Center, 9495 SW Locust St., Suite G, Portland, OR, 97223, USA. · K Papp Clinical Research and Probity Medical Research, Waterloo, Canada. · Dermatology Centre, Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK. · Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. · Medical Dermatology Specialists, Inc., Atlanta, GA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28074446
Probable:    Queen's University      
2017
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), School of Medicine, Queen's University, Kingston, ON (M.G.), and Centre for Dermatology and Probity Medical Research, Peterborough, ON (M.G.) - all in Canada · Oregon Medical Research Center, Portland (A.B.) · Altman Dermatology Associates, Arlington Heights, IL (M.B.) · Rockefeller University, New York (J.K.) · Hôpital de l'Archet, University of Nice-Sophia Antipolis, Nice, France (J.-P.L.) · Baylor Research Institute, Dallas (A.M.) · Charité Universitätsmedizin Berlin, Berlin (S.P.), Boehringer Ingelheim Pharma, Biberach (B.R.B.), and Boehringer Ingelheim Pharma, Ingelheim, (S.J.P.) - all in Germany · University of Texas Health Science Center, Houston (S.T.) · University of California, Los Angeles, School of Medicine, Los Angeles (H.S.) · and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (S.V., C.P., N.B., M.F., P.S.). · Pubmed 28423301
2017
  • From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. · D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. · From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. · D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. · Pubmed 28604347
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 50 total) written by Kim A. Papp about Psoriasis:

  • Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies. 2019
  • Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials. 2018
  • Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years. 2018
  • Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials. 2018
  • Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial. 2018
  • OBSERVE-5: Comparison of Etanercept-Treated Psoriasis Patients From Canada and the United States. 2018
  • Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis. 2018
  • Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials. 2018
  • Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices. 2018
  • Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis. 2017
Show List of Full Article Records
Google Searches

Learn more about Kim A. Papp using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Waterloo
Miscellaneous cities in Canada
Queen's University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Waterloo
2019
  • Keck School of Medicine of USC, University of Southern California, 1975 Zonal Avenue, Keith Administration Building, Room 510, Los Angeles, CA, 90089, USA. · Dermatologikum Berlin, Berlin, Germany. · SCIderm Research Institute, Hamburg, Germany. · The University of Melbourne, St. Vincent's Hospital Melbourne, Fitzroy and Probity Medical Research Inc., and Skin & Cancer Foundation Inc., Carlton, VIC, Australia. · Janssen Research & Development, LLC, Spring House, PA, USA. · K Papp Clinical Research and Probity Medical Research Inc., Waterloo, ON, Canada. · Pubmed 30417277
2018
  • Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · The McGovern School of Medicine of the University of Texas, Houston, Texas; Brain Health Consultants, Houston, Texas. · University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, California. · Oregon Medical Research Center, Portland, Oregon. · Skin Centre for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Valeant Pharmaceuticals North America LLC, Bridgewater, New Jersey. · Dow Pharmaceutical (a division of Valeant Pharmaceuticals North America LLC), Petaluma, California. · Pubmed 28985956
  • Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: · University of Connecticut Health Center and Probity Medical Research, Farmington, CT, USA. · Icahn School of Medicine at Mount Sinai, New York, NY, USA. · University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Oregon Medical Research Center, Portland, OR, USA. · Centre Dermatologique du Québec Métropolitain, Québec, QC, Canada. · K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · University of California, Los Angeles, CA, USA; School of Medicine, Los Angeles, CA, USA. · Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Melbourne, Parkville, Skin & Cancer Foundation Inc, Carlton, Probity Medical Research, Carlton, and St Vincent's Hospital Melbourne, Fitzroy VIC, Australia. · Jichi Medical University, Shimotsuke, Japan. · Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA. · AbbVie, North Chicago, IL, USA. · AbbVie, Redwood City, CA, USA. · Saint-Louis Hospital, AP-HP, Sorbonne Paris Cité Université Paris Diderot, INSERUM UMR 1163, Institut Imagine, Paris, France. Electronic address: · Pubmed 30097359
  • 1 K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · 2 Faculty of Medicine, Sherbrooke University, Sherbrooke, QC, Canada. · 3 Centre de Recherche Dermatologique du Québec Métropolitain, Quebec, QC, Canada. · 4 Lynde Institute for Dermatology and Probity Medical Research, Markham, ON, Canada. · 5 CHU de Québec, Laval University, Quebec, QC, Canada. · 6 Amgen Canada, Mississauga, ON, Canada. · Pubmed 29466863
  • Department of Dermatology, New York Medical College, Metropolitan Hospital, New York, New York. Electronic address: · K Papp Clinical Research and Probity Medical Research, Waterloo, Ontario. · Department of Medicine, University of Massachusetts School of Medicine, Worcester, Massachusetts. · Eli Lilly and Company, Indianapolis, Indiana. · Department of Rheumatology Research, Swedish-Providence-St. Joseph Health Systems and University of Washington School of Medicine, Seattle, Washington. · Pubmed 29559395
  • Probity Medical Research, and K. Papp Clinical Research, Waterloo, Ontario, Canada. · Analysis Group Inc., Boston, MA, USA. Electronic address: · AbbVie Inc., North Chicago, IL, USA. · Analysis Group Inc., Boston, MA, USA. · Pubmed 29304933
  • 1 University of Ottawa, Ottawa, ON, Canada. · 2 University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 SkiN Centre for Dermatology, Peterborough, ON, Canada. · 5 Probity Medical Research Inc., Waterloo, ON, Canada. · 6 University of Waterloo, Waterloo, ON, Canada. · 7 K. Papp Clinical Research, Waterloo, ON, Canada. · Pubmed 29056080
2017
  • Sapporo Skin Clinic, Sapporo, Japan. · Division of Dermatology, Kobe University, Kobe, Japan. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Kumamoto University, Kumamoto, Japan. · JR Sapporo Hospital, Sapporo, Japan. · Pfizer Japan Inc, Tokyo, Japan. · Pfizer Inc, New York, USA. · Probity Medical Research and K. Papp Clinical Research Inc., Waterloo, Ontario, Canada. · Pubmed 28714180
  • SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany. Electronic address: · Probity Medical Research, Waterloo, ON, Canada. · Oregon Medical Research Center, Portland, OR, USA. · Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA. · Epworth Hospital Department of Dermatology, University of Melbourne, Melbourne, VIC, Australia. · Comprehensive Center for Inflammation Medicine, University Medical School Schleswig-Holstein, University of Lübeck, Lübeck, Germany. · Merck & Co, Kenilworth, NJ, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 28596043
  • Bakersfield Dermatology, Bakersfield, California. Electronic address: · Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Germany. · Department of Dermatology, Hôpital Charles Nicolle, Université de Rouen, Rouen, France; Institut National de la Santé et de la Recherche Médicale U519, Rouen, France. · Catholic University of Rome, Rome, Italy. · Probity Medical Research, Waterloo, Ontario, Canada. · Celgene Corporation, Summit, New Jersy. · Hospital Universitario Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain. · Modern Research Associates, Dallas, Texas. · Pubmed 28416342
  • Oregon Medical Research Center, Portland, Oregon. Electronic address: · K. Papp Clinical Research and Probity Research Inc, Waterloo, Ontario, Canada. · Dermatology Center, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Center, Manchester, United Kingdom. · Janssen Research & Development LLC, Spring House, Pennsylvania; Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. · Janssen Research & Development LLC, Spring House, Pennsylvania. · Department of Dermatology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Pubmed 28057360
  • Department of Dermatology, University of Connecticut Health Center and Probity Medical Research, Farmington, Connecticut. Electronic address: · Central Dermatology PC, St Louis, Missouri. · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Psoriasis-Center, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Jichi Medical University, Shimotsuke, Tochigi, Japan. · Innovaderm Research, Montreal, Canada. · Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Dermatology, Paul Sabatier University, Toulouse, France. · Icahn School of Medicine at Mount Sinai, New York, New York. · Eli Lilly and Company, Indianapolis, Indiana. · Dermatologikum Hamburg and SCIderm, Hamburg, Germany. · Pubmed 27889292
  • Oregon Medical Research Center, Portland, Oregon. Electronic address: · Probity Medical Research, Waterloo, Ontario, Canada. · Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Dermatology, Temple University School, Philadelphia, Pennsylvania. · Department of Dermatology, Baylor College of Medicine, Houston, Texas. · Dow Pharmaceutical Sciences (a division of Valeant Pharmaceuticals North America, LLC), Petaluma, California. · Valeant Pharmaceuticals North America LLC, Bridgewater, New Jersey. · Pubmed 28711089
2016
  • K Papp Clinical Research and Probity Medical Research Inc, Waterloo, ON, Canada. · Innovaderm Research, Montreal, QC, Canada. · SKiN Centre for Dermatology and Probity Medical Research Inc, Peterborough, and Queens University, Kingston, ON, Canada. · Wake Forest Baptist Health, Winston-Salem, NC, USA. · Aarhus University Hospital, Aarhus, Denmark. · Southern California Dermatology, Santa Ana, CA, USA. · Dermatology Consulting Services, High Point, NC, USA. · Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business, Groton, CT, USA. · Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business, Groton, CT, USA. · Pubmed 27716172
  • Probity Medical Research, 139 Union Street East, Waterloo, ON, N2J 1C4, Canada. · Department of Dermatology, University of Southern California, Los Angeles, CA, USA. · Dermatologikum Hamburg, Hamburg, Germany. · AbbVie Inc., North Chicago, IL, USA. · Pubmed 26547918
  • Skin Centre for Dermatology, Peterborough, Ontario, Canada · Amgen Canada Inc, Mississauga, Ontario, Canada. · K Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Pubmed 26330052
  • University of Connecticut School of Medicine, Farmington, Connecticut. Electronic address: · Probity Medical Research, Waterloo, Ontario, Canada; K. Papp Medical Research, Waterloo, Ontario, Canada. · Icahn School of Medicine at Mount Sinai, New York, New York. · Dermatologikum Hamburg, Hamburg, Germany. · Paul Sabatier University, Toulouse, France. · Oregon Medical Research Center, Portland, Oregon. · Northwestern University, Feinberg School of Medicine, Chicago, Illinois. · Amgen Inc, Thousand Oaks, California. · Pubmed 27206759
  • Probity Medical Research and K. Papp Clinical Research Inc, Waterloo, Ontario, Canada. · Rockefeller University, New York, New York. · Wake Forest Baptist Health, Winston-Salem, North Carolina. · Dalhousie University, Halifax, Nova Scotia, Canada. · Comprehensive Center for Inflammation Research, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany. · Division of Dermatology, Tokyo Yamate Medical Center, Tokyo, Japan. · Department of Dermatology, University of Texas Medical School, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Cambridge, Massachusetts. · Dermatology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 26899199
  • Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: · Probity Medical Research, Waterloo, ON, Canada. · Eli Lilly & Co, Indianapolis, IN, USA. · Pubmed 26842297
2015
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA. · Department of Dermatology, University of Texas Medical School, Houston, TX, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Quintiles, Cambridge, MA, USA. · Present address: Statistical Consulting & Solutions, LLC, Brookline, MA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Specialty Care Medicines Development Group, Pfizer Inc, 219 E 42nd Street, 7th Floor Room 50, NYO 219/07/01, New York, NY, 10017, USA. · Pubmed 25951857
  • Baylor University Medical Center, Dallas, Texas. Electronic address: · Comprehensive Center for Inflammation Medicine, University Medical School Schleswig Holstein, Campus Lübeck, Lübeck, Germany. · Probity Medical Research, Waterloo, Ontario, Canada. · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · AbbVie Deutschland GmbH and Co KG, Ludwigshafen, Germany. · AbbVie Inc, North Chicago, Illinois. · Pubmed 26190240
  • Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · Probity Medical Research Inc, Waterloo, ON, Canada. · Oregon Medical Research Center PC, Portland, OR, USA. · Skin Search of Rochester, Rochester, NY, USA. · Innovaderm Research Inc, Montreal, QC, Canada. · Dermatology Clinic, Moncton, NB, Canada. · International Dermatology Research, Montreal, QC, Canada. · Ultranova Skincare, Barrie, ON, Canada. · Centre de Recherche Dermatologique du Québec Métropolitain, Quebec City, QC, Canada. · North Bay Dermatology Centre, North Bay, ON, Canada. · Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Novartis Institutes for BioMedical Research, Basel, Switzerland. · Pubmed 25828362
2013
  • Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington. Electronic address: · University of Toronto, Toronto, Ontario, Canada. · Probity Medical Research, Waterloo, Ontario, Canada. · Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada. · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Specialty Care, Pfizer Inc, Collegeville, Pennsylvania. · Pubmed 23981683
2012
  • Probity Medical Research, Waterloo, ON. · Pubmed 22713438
  • Probity Medical Research, Waterloo, Ontario, Canada. · Dermatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia. · Department of Medicine (Dermatology) and Department of Dermatology, The University of Melbourne, St Vincent's Hospital Melbourne, Melbourne, Victoria and Skin and Cancer Foundation, Carlton, Victoria, Australia. · Pharmacokinetics and Drug Metabolism, Amgen, Seattle, Washington, USA. · Early Development, Amgen, Thousand Oaks, California, USA. · Biostatistics, Amgen, South San Francisco, California, USA. · Rockefeller University, New York, New York, USA. · Medical Sciences, Amgen, Seattle, Washington, USA. · Medical Sciences, Amgen, Seattle, Washington, USA. Electronic address: · Pubmed 22622425
  • Probity Medical Research, Waterloo, ON, Canada. · Pubmed 22455412
  • Probity Medical Research, Waterloo, Ontario, Canada. · Pubmed 20850895
  • Probity Medical Research, Waterloo, Ontario, Canada. · Pubmed 23134986
2011
2010
Miscellaneous cities in Canada
2018
  • Probity Medical Research and K Papp Clinical Research, Waterloo, Canada. Electronic address: · Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts. · New York Medical College, Metropolitan Hospital, New York, New York. · Dermatology Centre, Salford Royal Hospital, University of Manchester, National Institute for Health Research Biomedical Research Centre, Manchester, United Kingdom. · UCB Biosciences Inc, Raleigh, North Carolina. · UCB Pharma, Brussels, Belgium. · Oregon Medical Research Center, Portland, Oregon. · Pubmed 29609013
2017
  • Oregon Medical Research Center, 9495 SW Locust St., Suite G, Portland, OR, 97223, USA. · K Papp Clinical Research and Probity Medical Research, Waterloo, Canada. · Dermatology Centre, Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK. · Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. · Medical Dermatology Specialists, Inc., Atlanta, GA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28074446
Queen's University
2017
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), School of Medicine, Queen's University, Kingston, ON (M.G.), and Centre for Dermatology and Probity Medical Research, Peterborough, ON (M.G.) - all in Canada · Oregon Medical Research Center, Portland (A.B.) · Altman Dermatology Associates, Arlington Heights, IL (M.B.) · Rockefeller University, New York (J.K.) · Hôpital de l'Archet, University of Nice-Sophia Antipolis, Nice, France (J.-P.L.) · Baylor Research Institute, Dallas (A.M.) · Charité Universitätsmedizin Berlin, Berlin (S.P.), Boehringer Ingelheim Pharma, Biberach (B.R.B.), and Boehringer Ingelheim Pharma, Ingelheim, (S.J.P.) - all in Germany · University of Texas Health Science Center, Houston (S.T.) · University of California, Los Angeles, School of Medicine, Los Angeles (H.S.) · and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (S.V., C.P., N.B., M.F., P.S.). · Pubmed 28423301
2017
  • From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. · D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. · From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. · D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. · Pubmed 28604347
Dalhousie University
2016
  • From the Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago (K.B.G.) · Oregon Medical Research Center, Portland (A.B.) · K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), and the Department of Medicine, Division of Dermatology, Dalhousie University, Halifax, NS (R.G.L.) - both in Canada · the Department of Dermatology, University of Münster, Münster (T.L.), and SCIderm Research Institute and Dermatologikum Hamburg, Hamburg (K.R.) - both in Germany · the Department of Dermatology, Jichi Medical University, Shimotsuke-shi, Japan (M.O.) · Lilly Research Laboratories, Eli Lilly, Indianapolis (D.A., S.G.B., D.K.B., G.S.C., J.E., R.J.K., T.M.M., B.J.N., O.O.O., R.J.S., F.Z., L.M.) · and the Department of Dermatology, Saint Louis University School of Medicine, St. Louis (C.L.L.). · Pubmed 27299809
18 Other Locations Show
Yearly article counts 1811831210330
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.